Literature DB >> 7810685

Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle.

K M Mohazzab1, M S Wolin.   

Abstract

Sources of superoxide anion (O2-.) production in calf pulmonary artery smooth muscle homogenate and subcellular fractions were examined in this study by measurement of the chemiluminescence produced by the reaction of O2-. with 50 microM lucigenin, because recent evidence suggests that endogenously produced reactive O2 species appear to mediate certain vascular responses. In the homogenate fraction, an NADH (0.1 mM)-dependent oxidoreductase activity was the major detected source of chemiluminescence. NADPH (0.1 mM) produced only 3% of the O2-. observed with NADH. Quantitation of certain other potential sources of O2-. (under optimized conditions), including xanthine oxidase (0.1 mM hypoxanthine), mitochondria (5 mM succinate + 30 microM antimycin), cyclooxygenase/lipoxygenase (1 microM arachidonic acid + 0.1 mM NADPH), or autooxidation (0.1 mg/ml superoxide dismutase), resulted in the detection of minimal amounts (< 3% of NADH) of chemiluminescence. Estimation of mitochondrial O2-. production from tissue respiration rates suggests that lucigenin is a poor detector of intramitochondrial O2-.. These observations were confirmed by examination of chemiluminescence produced by subcellular fractions, where the major activity detected was an NADH oxidoreductase, which fractionated in a manner closely matching the activity of the microsomal marker enzyme rotenone-insensitive NADH-cytochrome c reductase. Because this NADH oxidoreductase appears to be a major vascular smooth muscle-derived source of O2-. production, this system has the potential to be an important endogenous source for the generation of vasoactive reactive O2 species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810685     DOI: 10.1152/ajplung.1994.267.6.L815

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  High-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathy.

Authors:  Peter A Hecker; Tatiana F Galvao; Karen M O'Shea; Bethany H Brown; Reney Henderson; Heather Riggle; Sachin A Gupte; William C Stanley
Journal:  Nutrition       Date:  2012-02-02       Impact factor: 4.008

Review 3.  Cellular and molecular mechanisms of endothelial cell dysfunction.

Authors:  D G Harrison
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

4.  Nox4-dependent activation of cofilin mediates VSMC reorientation in response to cyclic stretching.

Authors:  Marcelo F Montenegro; Alejandra Valdivia; Alexander Smolensky; Kiran Verma; W Robert Taylor; Alejandra San Martín
Journal:  Free Radic Biol Med       Date:  2015-05-19       Impact factor: 7.376

Review 5.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 6.  The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics.

Authors:  Alejandra Valdivia; Charity Duran; Alejandra San Martin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  Coronary artery spasm related to thiol oxidation and senescence marker protein-30 in aging.

Authors:  Shinya Yamada; Shu-ichi Saitoh; Hirofumi Machii; Hiroyuki Mizukami; Yasuto Hoshino; Tomofumi Misaka; Akihito Ishigami; Yasuchika Takeishi
Journal:  Antioxid Redox Signal       Date:  2013-02-19       Impact factor: 8.401

8.  Local production of O2- by NAD(P)H oxidase in the sarcoplasmic reticulum of coronary arterial myocytes: cADPR-mediated Ca2+ regulation.

Authors:  Fan Zhang; Si Jin; Fan Yi; Min Xia; William L Dewey; Pin-Lan Li
Journal:  Cell Signal       Date:  2007-12-08       Impact factor: 4.315

9.  Impaired nitric oxide-mediated flow-induced coronary dilation in hyperhomocysteinemia: morphological and functional evidence for increased peroxynitrite formation.

Authors:  Zoltan Ungvari; Anna Csiszar; Zsolt Bagi; Akos Koller
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.

Authors:  T Münzel; S Kurz; S Rajagopalan; M Thoenes; W R Berrington; J A Thompson; B A Freeman; D G Harrison
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.